Article

Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease Pathology

2021-11-10

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Changes in soluble amyloid-beta (Aβ) levels in cerebrospinal fluid (CSF) are detectable at early preclinical stages of Alzheimer's disease (AD). However, whether Aβ levels can predict downstream AD pathological features in cognitively unimpaired (CU) individuals remains unclear. With this in mind, we aimed at investigating whether a combination of soluble Aβ iso...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 25991902-1739-5020-883d-2f3a9bfa04e6
DOI: 10.21203/rs.3.rs-1032345/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Soluble Amyloid-Beta Isoforms Predict Downstream Alzheimer’s Disease PathologyDOI 10.21203/rs.3.rs-1032345/v1Read

Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuumSemantic proximity Read

Aβ-related Cerebrospinal Fluid Proteins in Alzheimer’s Disease Reflect Gene Expression Levels Found in The Healthy CortexSemantic proximity Read

CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease.Semantic proximity Read

Alzheimer’s disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionSemantic proximity Read

Plasma and CSF proteomic signatures related to Alzheimer’s, α-synuclein, or vascular pathologies and clinical declineSemantic proximity Read

Performance of Plasma Amyloid β, Total Tau and Neurofilament Light Chain Levels for Alzheimer’s Disease IdentificationSemantic proximity Read

Predicting Amyloid Positivity Through Proteomic and Machine Learning ApproachesSemantic proximity Read

Elucidating the neuropathological and molecular heterogeneity of amyloid-beta and tau in Alzheimer's disease through machine learning and transcriptomic integrationSemantic proximity Read

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkersSemantic proximity Read

Predicting Progression & Cognitive Decline in Amyloid-Positive Patients with Alzheimer's DiseaseSemantic proximity Read

Predicting Autopsy-Confirmed Neuropathology across Clinical, Neuroimaging, and CSF Biomarkers using Machine LearningSemantic proximity Read

Integrative analyses of neuroimaging, clinical, and multi-omics data identified meaningful Alzheimer’s disease progression subtypesSemantic proximity Read